We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
-12.49%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$48.6B
AUM Growth
-$4.2B
Cap. Flow
+$3.6B
Cap. Flow %
7.4%
Top 10 Hldgs %
10.29%
Holding
4,108
New
835
Increased
964
Reduced
740
Closed
743

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$340M
2
BAC icon
Bank of America
BAC
+$302M
3
CI icon
Cigna
CI
+$294M
4
TSM icon
TSMC
TSM
+$275M
5
UNP icon
Union Pacific
UNP
+$256M

Top Sells

Rank Stock Value
1
VZ icon
Verizon
VZ
+$426M
2
SPGI icon
S&P Global
SPGI
+$413M
3
BKNG icon
Booking.com
BKNG
+$264M
4
CMCSA icon
Comcast
CMCSA
+$256M
5
TFX icon
Teleflex
TFX
+$241M

Sector Composition

Rank Sector Weight
1 Healthcare 17.59%
2 Financials 16.96%
3 Technology 16.37%
4 Consumer Discretionary 9.33%
5 Industrials 7.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XPDBU
3951
DELISTED
Power & Digital Infrastructure Acquisition II Corp. Unit
XPDBU
-185,800
Closed -$1.86M
ALTUW
3952
CALL
DELISTED
Altitude Acquisition Corp Warrant
ALTUW
-170,000
Closed -$1.69M
ALTU
3953
DELISTED
Altitude Acquisition Corp
ALTU
-792,335
Closed -$7.88M
SOVO
3954
DELISTED
Sovos Brands, Inc. Common Stock
SOVO
-19,183
Closed -$273K
GRCL
3955
DELISTED
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
-38,752
Closed -$89K
SUNW
3956
DELISTED
Sunworks, Inc.
SUNW
-89,095
Closed -$224K
NETI
3957
DELISTED
Eneti Inc.
NETI
-26,717
Closed -$169K
PNT
3958
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
-38,110
Closed -$304K
CLINU
3959
DELISTED
Clean Earth Acquisitions Corp. Unit
CLINU
-454,246
Closed -$4.56M
VRTV
3960
DELISTED
VERITIV CORPORATION
VRTV
-1,850
Closed -$248K
SONX
3961
DELISTED
Sonendo, Inc.
SONX
-22,948
Closed -$93K
JGGCU
3962
DELISTED
Jaguar Global Growth Corporation I Unit
JGGCU
-250,000
Closed -$2.51M
EQRX
3963
DELISTED
EQRx, Inc. Common Stock
EQRX
-71,807
Closed -$298K
ICPT
3964
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
-26,836
Closed -$436K
THRN
3965
DELISTED
Thorne Healthtech, Inc. Common Stock
THRN
-16,810
Closed -$107K
RAD
3966
DELISTED
Rite Aid Corporation
RAD
-470,913
Closed -$4.12M
CELL
3967
DELISTED
PhenomeX Inc. Common Stock
CELL
-18,832
Closed -$134K
SYNH
3968
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
-7,714
Closed -$625K
INFI
3969
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
-316,146
Closed -$359K
APPH
3970
DELISTED
AppHarvest, Inc. Common Stock
APPH
-50,159
Closed -$270K
UNVR
3971
DELISTED
Univar Solutions Inc.
UNVR
-772,164
Closed -$24.8M
APPHW
3972
CALL
DELISTED
AppHarvest, Inc. Warrants
APPHW
-132,123
Closed -$711K
BBIG
3973
DELISTED
Vinco Ventures, Inc. Common Stock
BBIG
-83,523
Closed -$3.64M
USX
3974
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
-24,903
Closed -$97K
GSRMU
3975
DELISTED
GSR II Meteora Acquisition Corp. Unit
GSRMU
-460,782
Closed -$4.65M

Similar funds

Marshall Wace's Q2 2022 Portfolio in Review

As of Q2 2022, Marshall Wace held 4,108 positions worth $48.6B, down 8% from $52.8B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Marshall Wace deployed $3.6B of net new capital in Q2 2022, opening 835 new positions and adding to 964 existing holdings. Its largest new stake was Eli Lilly: 1,133,393 shares worth $367M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Verizon, an estimated $426M trimmed.

  • Marshall Wace's largest Q2 2022 buy was Eli Lilly: 1,133,393 shares worth $367M.
  • Marshall Wace added most to Bank of America in Q2 2022, an estimated $302M increase.
  • Marshall Wace's biggest Q2 2022 reduction was Verizon, cutting an estimated $426M.
  • Marshall Wace fully exited Teleflex in Q2 2022, selling an estimated $241M.
  • Marshall Wace's ten largest holdings make up 10% of its $48.6B portfolio in Q2 2022.
  • Marshall Wace opened 835 new positions and closed 743 in Q2 2022.
  • Marshall Wace's portfolio value fell 8% quarter-over-quarter to $48.6B.

Based on Marshall Wace's 13F filing for Q2 2022, filed 15 Aug 2022.